학술논문

CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)
Document Type
Journal
Source
EUROPEAN JOURNAL OF CANCER; SEP 2015, 51 pS708-pS708, 1p. Supplement: 3
Subject
Language
English
ISSN
18790852